Fig. 2
Correlation of CD163+M2 macrophages with GC patients’ overall survival. Kaplan–Meier survival curves for OS based on CD163 in total GC patients (a); in different locations (b); in different TNM stages (c); with or without lymph node metastasis (d); in different pathological classifications (e); and based on CD163 combined with FOXP3 in total and certain subgroups of GC (f)